Latest ImmunityBio News & Updates

See the latest news and media coverage for ImmunityBio. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ImmunityBio

Biotechnology company developing immunotherapies for cancer and infectious diseases

immunitybio.com
Headquarters
San Diego, United States
Founded year
2014
Company type
Public company
Number of employees
680–1,000
Industry
Pharmaceuticals

Last updated

Latest news about ImmunityBio

In short: ImmunityBio reported Q3 product-revenue growth, but a revenue miss and wider loss sent shares lower.

Company announcements

ImmunityBio

ImmunityBio receives FDA approval expansion for ANKTIVA

The indication now covers BCG-unresponsive non-muscle-invasive bladder cancer with papillary-only tumors, significantly increasing the addressable patient population.

Unlock all announcements with a

Media coverage

BioSpace

ImmunityBio Reports Label Expansion and Additional Global Approval with Q3 2026 Net Product Revenue of $48.7 Million, Up 53% Year-Over-Year and First Nine Months U.S. Revenue ...

Q3 2026 net product revenue of $48.7 million, up 53% year-over-year, driven by continued adoption among U.S. urologists and strong market access 2026 year-to-date net...

Unlock all articles with a

Never miss news about ImmunityBio

Track ImmunityBio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.